Table 4.
H. pylori + |
H. pylori + CagA + |
||||||
---|---|---|---|---|---|---|---|
Cohort | n | PRa | 95% CIa | Ptrenda | PRa | 95% CIa | Ptrenda |
All | |||||||
Whitesb | 1,908 | 0.83 | 0.77, 0.91 | <0.001 | 0.83 | 0.75, 0.93 | 0.001 |
African American | 1,023 | 1.01 | 0.97, 1.05 | 0.625 | 1.04 | 1.00, 1.09 | 0.078 |
NYUWHS | |||||||
Whitesb | 412 | 0.79 | 0.69, 0.90 | <0.001 | 0.76 | 0.62, 0.92 | 0.006 |
African American | 55 | 0.99 | 0.74, 1.31 | 0.920 | 0.92 | 0.66, 1.29 | 0.630 |
PLCO | |||||||
Whitesb | 1,098 | 0.85 | 0.74, 0.98 | 0.020 | 0.85 | 0.71, 1.03 | 0.094 |
African American | 98 | 1.03 | 0.81, 1.30 | 0.815 | 1.13 | 0.82, 1.55 | 0.449 |
SCCS | |||||||
Whitesb | 172 | 0.92 | 0.80, 1.06 | 0.258 | 1.07 | 0.83, 1.39 | 0.589 |
African American | 590 | 1.02 | 0.97, 1.06 | 0.447 | 1.03 | 0.98, 1.09 | 0.231 |
MEC | |||||||
Whitesc | 226 | 0.82 | 0.65, 1.05 | 0.120 | 0.92 | 0.67, 1.28 | 0.635 |
African American | 280 | 0.94 | 0.86, 1.02 | 0.120 | 0.98 | 0.89, 1.07 | 0.609 |
Japanese American | 570 | 0.78 | 0.70, 0.87 | <0.001 | 0.72 | 0.63, 0.83 | <0.001 |
Latino | 329 | 0.98 | 0.91, 1.07 | 0.667 | 0.96 | 0.85, 1.09 | 0.538 |
Native Hawaiian | 96 | 1.04 | 0.77, 1.40 | 0.810 | 1.06 | 0.77, 1.45 | 0.739 |
Abbreviations: +, sero-positive; CagA, Cytotoxin-associated gene A; CI, confidence interval; MEC, Multiethnic cohort study; n, number; NYUWHS, New York University Women’s Health Study; PLCO, Prostate, Lung, Colorectal, and Ovarian Cancer Screening Study; PR, prevalence ratio; SCCS, Southern Community Cohort Study.
PR and 95% CI estimated for one increment increase in year of birth category (<1925, 1925-1935, 1936-1945, 1946-1953, and ≥1954) estimated by Log-binomial regression adjusted for sex, education (≤HS, technical school or some college, ≥college), and case control status; for each cohort the lowest year of birth category was considered as reference.
Includes both non-Latino and Latino whites.
Non-Latino whites only.